Boston Commerce FY26 loss at ₹0.58 cr; sales up 153%
Boston Commerce
BOSTONBIO
Ask AI
Share price and the latest filing context
Boston Commerce share price was ₹7.21 as of June 3, 2026, following a series of regulatory filings around its annual results. The company, listed under scrip code 531458, disclosed the outcome of its board meeting held on May 30, 2026. That meeting was convened to consider and approve audited financial results for the quarter and year ended March 31, 2026. The disclosures also included the auditors’ observations, which investors typically track closely during audited-result season.
Board meeting on May 30: what the company approved
In its board meeting outcome filed on May 30, 2026 (timestamped 17:36:47), Boston Commerce said the board approved audited standalone financial results for FY26. The company reported a net loss of ₹0.5808 crore for the full year. For Q4 FY26, it reported a net loss of ₹0.6458 crore. Alongside the financial approval, the auditors highlighted non-payment of FY26 TDS dues, as disclosed in the filing.
Q4 FY26: loss widened, no sales reported
For the quarter ended March 2026, Boston Commerce reported a net loss of ₹0.65 crore. This compares with a net loss of ₹0.49 crore in the quarter ended March 2025, as per the reported figures in the provided text. On the revenue line, the company reported no sales for the March 2026 quarter. In the March 2025 quarter, sales were reported at ₹0.19 crore. The absence of quarterly sales, combined with a higher loss number, sets the tone for how the year ended for the company.
FY26 performance: sales rise, but losses persist
For the full year ended March 2026, Boston Commerce posted sales of ₹0.48 crore, up from ₹0.19 crore in the year ended March 2025. The text explicitly states the sales growth at 152.63% year-on-year. Despite this increase in annual sales, the company remained loss-making, with FY26 net loss reported at ₹0.58 crore versus ₹0.55 crore in FY25. The figures also appear in another summary in the text as ₹4.84 million revenue versus ₹1.93 million a year earlier, and net loss of ₹5.81 million versus ₹5.47 million.
Earnings quality and audit flags: TDS dues highlighted
A key point in the audited outcome was the auditors’ highlight on non-payment of FY26 TDS dues. The filing does not quantify the unpaid amount in the text provided, but the mention itself is material for governance and compliance tracking. Investors often look for such notes because tax-related delays can affect cash management, compliance timelines, and future disclosures. The same board outcome communication links this audit highlight directly with the approval of audited standalone results.
Trading window closure and SEBI insider trading compliance
Separately, the company disclosed that it would close its trading window starting April 1, 2026, for designated persons and their immediate relatives. The stated purpose was compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction was to remain until 48 hours after the company announces its audited financial results for the year ended March 31, 2026. During this period, insiders are prohibited from buying or selling Boston Commerce shares, as per the disclosure.
Earlier quarterly disclosure: Q3 FY26 snapshot and nine-month trend
The text also references the company’s unaudited financial results for the quarter ended December 31, 2025, approved at a board meeting held on February 13, 2026. For Q3 FY26, Boston Commerce reported revenue of ₹0.0585 crore, down from ₹0.2447 crore in Q2 FY26, and a net loss of ₹0.0144 crore. At the nine-month level, the company reported total revenue of ₹0.4837 crore and net profit of ₹0.0651 crore. In the corresponding nine-month period last year, it reported zero revenue and a net loss of ₹0.0568 crore, as stated in the text.
Company details referenced in the filing
Boston Commerce was referenced as formerly known as Boston Bio Systems Limited. The unaudited results were stated to be prepared under Indian Accounting Standards (Ind AS). The statutory auditors named in the text were Sunit M Chhatbar & Co, who issued an unqualified limited review report confirming compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company was also described as operating as a single reportable segment for Ind AS-108 purposes.
Key numbers at a glance
Why the FY26 filing matters for investors
The FY26 filing combines three investor-relevant threads: a year-on-year rise in revenue, continued losses, and an audit highlight related to TDS dues. The Q4 disclosure stands out because the company reported zero sales for the quarter, even as the quarterly loss widened versus the year-ago quarter. For small-cap counters like Boston Commerce, audited filings and audit notes often influence investor perception more than management commentary, especially when disclosures flag statutory dues. The market will also track follow-on compliance updates that typically come after audited results, including any clarifications around statutory payments.
Conclusion
Boston Commerce’s audited FY26 results show that sales increased to ₹0.48 crore, but the company still reported a full-year net loss of ₹0.5808 crore and a Q4 net loss of ₹0.6458 crore with no quarterly sales. The auditors’ note on non-payment of FY26 TDS dues adds a compliance angle to the financial outcome. With the audited results now approved and disclosed, investors are likely to watch subsequent filings for any additional details tied to statutory dues and related compliance actions.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker